GT Biopharma Ownership | Who Owns GT Biopharma?

GT Biopharma Ownership Summary

GT Biopharma is owned by 7.23% institutional investors, 2.74% insiders, and 90.04% retail investors. Seacrest wealth management is the largest institutional shareholder, holding 1.27% of GTBP shares. Spartan Extended Market Index Pool E is the top mutual fund, with 0.20% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	GT Biopharma	7.23%	2.74%	90.04%
Sector	Healthcare Stocks	232.64%	10.66%	-143.30%
Industry	Biotech Stocks	382.13%	10.41%	-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Seacrest wealth management	50.00K	1.27%	$36.62K
Jane street group	26.02K	0.66%	$20.43K
Two sigma securities	17.07K	0.62%	$10.01K
Geode capital management	19.26K	0.49%	$15.12K
Morgan stanley	18.60K	0.47%	$14.60K
Coston, mcisaac & partners	17.09K	0.43%	$13.00K
Wells fargo & company/mn	16.04K	0.41%	$12.59K
Cerity partners	15.00K	0.38%	$11.78K
Am investment strategies	15.00K	0.38%	$12.00K
Verdence capital advisors	13.00K	0.33%	$10.21K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Seacrest wealth management	50.00K	0.00%	$36.62K
Coston, mcisaac & partners	17.09K	0.00%	$13.00K
Am investment strategies	15.00K	0.00%	$12.00K
Wolff wiese magana	5.00K	0.00%	$3.93K
Two sigma securities	17.07K	0.00%	$10.01K
Verdence capital advisors	13.00K	0.00%	$10.21K
Parsons capital management inc/ri	10.90K	0.00%	$8.56K
Newbridge financial services group	3.75K	0.00%	$2.94K
Swan capital	1.00K	0.00%	$785.00
Triumph capital management	1.66K	0.00%	$1.30K

Top Buyers

Holder	Shares	% Assets	Change
Seacrest wealth management	50.00K	0.00%	50.00K
Jane street group	26.02K	-	26.02K
Coston, mcisaac & partners	17.09K	0.00%	17.09K
Two sigma securities	17.07K	0.00%	17.07K
Cerity partners	15.00K	-	15.00K

Top Sellers

Holder	Shares	% Assets	Change
Drw securities	-	-	-142.38K
Bank of montreal /can/	10.83K	-	-81.70K
Renaissance	-	-	-26.30K
Vanguard group	-	-	-10.50K
Advisor group	5.07K	-	-6.38K

New Positions

Holder	Shares	% Assets	Change	Value
Seacrest wealth management	50.00K	0.00%	50.00K	$36.62K
Jane street group	26.02K	-	26.02K	$20.43K
Coston, mcisaac & partners	17.09K	0.00%	17.09K	$13.00K
Two sigma securities	17.07K	0.00%	17.07K	$10.01K
Am investment strategies	15.00K	0.00%	15.00K	$12.00K

Sold Out

Holder	Change
Front row advisors	-1.00
Blue bell private wealth management	-10.00
Ghp investment advisors	-33.00
Mount yale investment advisors	-46.00
Clearstead advisors	-865.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	29	38.10%	284,740	-23.91%	7	3.96%	20	185.71%	5	25.00%
Sep 30, 2025	20	-	374,216	92.24%	13	19.59%	7	-36.36%	4	33.33%
Jun 30, 2025	21	5.00%	189,926	90.52%	8	44.82%	11	120.00%	3	-40.00%
Mar 31, 2025	20	11.11%	99,688	-91.98%	4	0.10%	5	-28.57%	5	150.00%
Dec 31, 2024	18	20.00%	1,242,247	-0.30%	65	2.11%	7	133.33%	2	-33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Spartan Extended Market Index Pool E	4.50K	0.20%	4.26K
Spartan Extended Market Index Pool F	4.71K	0.13%	90.00
Dimensional US Core Equity USD Acc	2.20K	0.10%	-
BlackRock Extended Equity Market K	1.16K	0.05%	-
Fidelity Extended Market Index	12.72K	0.05%	-
Dimensional US Sustainability Core 1 ETF	1.64K	0.05%	-
DFA US Sustainability Core 1	799.00	0.04%	-
Extended Equity Market Fund K	1.12K	0.03%	-22.00
Vanguard Institutional Extnd Mkt Idx Tr	7.22K	0.03%	-
Spartan Total Market Index Pool E	411.00	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Apr 11, 2023	Breen Michael Martin	Executive Chairman/Interim CEO	Buy	$25.00K
Apr 06, 2023	Ohri Manu	CFO & Secretary	Buy	$25.00K
Dec 22, 2020	Wendel Bruce	-	Buy	$12.19K
Nov 16, 2020	Wendel Bruce	-	Buy	$10.26K
Dec 22, 2020	Wendel Bruce	-	Buy	$3.85K

Insider Transactions Trends

Date	Buy	Sell
2023 Q2	2	-
2023 Q1	-	-
2022 Q3	-	-
2022 Q2	-	-
2022 Q1	-	-

GTBP Ownership FAQ

Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 7.23%, followed by 2.74% insiders and 90.03% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 382.13%, which GT Biopharma falls below.

Who owns the most shares of GT Biopharma?

GT Biopharma’s largest shareholders are Seacrest wealth management (50K shares, 1.27%), Jane street group (26.02K shares, 0.66%), and Two sigma securities (17.06K shares, 0.62%). Together, they hold 2.54% of GT Biopharma’s total shares outstanding.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is GT Biopharma’s biggest shareholder by percentage of total assets invested?

Seacrest wealth management is GT Biopharma’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 50K GT Biopharma shares, valued at 36.62K$.

Who is the top mutual fund holder of GT Biopharma shares?

Spartan Extended Market Index Pool E is the top mutual fund holder of GT Biopharma shares, with 0.20% of its total shares outstanding invested in 4.5K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools